BackAEON Biopharma Overview

AEON Biopharma Accounts Payable

Track AEON Biopharma's accounts payable ($1.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$1.48M
↓ 39.23% YoYΔ $-956000.00 vs prior year quarter

Peer average

Loading

AEON Biopharma Accounts Payable History

Loading

AEON Biopharma vs. peers: Accounts Payable Comparison

Loading

AEON Biopharma Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AEON Biopharma (AEON) FAQ

AEON Biopharma (AEON) currently reports a accounts payable of $1.5M as of March 2026. That compares with $2.4M in the prior-year period — down 39.2% year over year. Use the charts on this page to explore AEON Biopharma's accounts payable history and peer comparisons.

AEON Biopharma's accounts payable decreased from $2.4M to $1.5M — a 39.2% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AEON Biopharma reported $1.5M in accounts payable as of March 2026. That compares with $2.4M in the prior-year period — down 39.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $1.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AEON Biopharma, and consider following AEON for alerts when major investors trade the stock.